Cancer

MIT researchers have found that lung tumors such as this one contain stem-cell-like cells that drive tumor aggression. In this image, those cells are tagged with a green fluorescent protein.

Biologists identify key step in lung cancer evolution

Blocking the transition to a more aggressive state could offer a new treatment strategy.

May 10, 2017

“I decided to come to MIT because it was the best place to do engineering, and I eventually settled on materials science, because I felt like it was really applicable to all sorts of fields, including medicine," MIT senior Tiffany Yeh says.

Engineer, pianist, global citizen

Senior Tiffany Yeh explores health care and poverty through working abroad, and cultivates her love of music while at home.

May 4, 2017

MIT researchers created this colon tumor by delivering RNA encapsulated in lipid nanoparticles to the colon. The RNA can activate or delete specific genes, leading to tumor growth.

New model could speed up colon cancer research

Introducing genetic mutations with CRISPR offers a fast and accurate way to simulate the disease.

May 1, 2017

Hadley Sikes, an associate professor in the Department of Chemical Engineering, is one of an increasing number of MIT faculty members who do what might best be called public engineering — emphasizing the interaction between society and technology.

The creation of a public engineer

Hadley Sikes is bridging the gap between engineering and public policy to solve big social problems at home and abroad.

April 27, 2017

MIT Professor Tyler Jacks, director of the Koch Institute for Integrative Cancer Research, recently testified before a U.S. House Committee on Oversight and Government Reform hearing titled, “Federally Funded Cancer Research: Coordination and Innovation.” He is seen here presenting recommendations from the Cancer Moonshot Blue Ribbon Panel report to the National Cancer Advisory Board in Septem...

Tyler Jacks: NIH budget cuts would have “devastating” effects on progress against cancer

Koch Institute director advocates support for biomedical research in testimony before the House Committee on Oversight and Government Reform.

April 10, 2017

A high-magnification micrograph of an ovarian clear cell carcinoma. The images show, focally, the characteristic clear cells with prominent nucleoli and the typical hyaline globules.

New technology can detect tiny ovarian tumors

“Synthetic biomarkers” could be used to diagnose ovarian cancer months earlier than now possible.

April 10, 2017

A deconvolved wide-field fluorescence microscope image of human HeLa cancer cells, during late anaphase/early telophase, showing a lagging chromosome. If this fails to get into a daughter cell, it may lead to aneuploidy.

Study helps explain varying outcomes for cancer, Down Syndrome

Differences in chromosome number may underlie variation among genetically identical individuals.

April 6, 2017

Engineers at MIT have devised a microfluidic technique to capture and count circulating plasma cells from small samples of blood. The technique, which relies on conventional blood draws, may provide patients with a less painful test for multiple myeloma.

Method may help myeloma patients avoid painful biopsies

Microfluidic device isolates plasma cells from blood rather than bone marrow.

April 4, 2017

MIT researchers have devised a new vaccine candidate for the Zika virus. “It functions almost like a synthetic virus, except it’s not pathogenic and it doesn’t spread,” says postdoc Omar Khan.

Progress toward a Zika vaccine

Researchers program RNA nanoparticles that could protect against the virus.

March 29, 2017

Research scientist Bogdan Fedeles and postdoc Supawadee Chawanthayatham have discovered a mutational signature that reveals liver cell exposure to aflatoxin, a potent carcinogen.

Detecting mutations could lead to earlier liver cancer diagnosis

New technique can reveal exposure to aflatoxin, a potent carcinogen, before tumors develop.

March 27, 2017

By tethering hundreds of tiny particles to the surfaces of tumor cells in the presence of a mechanical force, an MIT team made the cells much more vulnerable to attack by a drug that triggers cancer cells to commit suicide.

Tethered nanoparticles make tumor cells more vulnerable

New strategy could improve performance of some immune-based drugs.

March 20, 2017

Left to right: MIT Professor Angelika Amon, Glenn Foundation President and Director Mark Collins, University of Rochester Professor Vera Gorbunova, and MIT Professor Leonard Guerente.

Vera Gorbunova delivers eighth Paul F. Glenn Lecture

Expert on long-lived rodents provides insights into research on longevity and cancer resistance.

February 16, 2017

MIT Professor Regina Barzilay has struck up new research collaborations, drawn in MIT students, launched projects with local doctors, and begun empowering cancer treatment with the machine-learning insight that has already transformed many areas of modern life.

Putting data in the hands of doctors

Computer scientist Regina Barzilay empowers cancer treatment with machine learning.

February 16, 2017

Coming together for immuno-oncology

Takeda's $1 million gift to the MIT Koch Institute will advance research into how the immune system affects cancer.

February 13, 2017

MIT researchers have developed a portable technology, known as Seq-Well, that can rapidly prepare the RNA of many cells for sequencing simultaneously.

Making single-cell RNA sequencing widely available

Portable tool could help scientists learn more about cells’ roles in many diseases.